Sandra M. Gurrola - 07 Feb 2025 Form 4 Insider Report for Eterna Therapeutics Inc. (ERNA)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ERNA	Stock Option (Right to buy)	Award	$0	+150,000		$0.000000	150,000	07 Feb 2025	Common Stock	150,000	$0.3400	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Subject to continued service, one-third of the shares underlying the stock option will vest on the first anniversary of the grant date, and the remaining shares underlying the stock option will vest in 24 substantially equal monthly installments thereafter.